Analyze Diet
The Veterinary record2009; 164(18); 558-559; doi: 10.1136/vr.164.18.558

Intrapleural fibrinolytic therapy in the management of septic pleuropneumonia in a horse.

Abstract: No abstract available
Publication Date: 2009-05-05 PubMed ID: 19411687DOI: 10.1136/vr.164.18.558Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Case Reports
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research involves the treatment of septic pleuropneumonia – a serious respiratory ailment – in a young horse. The study utilized intrapleural fibrinolytic therapy, a process that aims to dissolve fibrinous adhesions to improve drainage of pleural fluid and lessen pleural loculations.

Background and Selection of Subject

  • The study revolves around the case of a three-year-old thoroughbred colt with a history of fever and respiratory disease for seven days. This respiratory disease has a known high rate of morbidity and mortality in horses.
  • Initial physical examination and blood tests revealed the horse had a high temperature, increased heart rate, heart sounds radiating in the thoracic cavity, decreased bronchovesicular sounds, leukocytosis (an increase in white blood cells), neutrophilia (a rise in a specific type of white blood cells), and hyperfibrinogenaemia (excessive fibrinogen in the blood).

Diagnostic Procedures

  • Thoracic ultrasonography was carried out which disclosed bilateral pleural effusion and an abundance of fibrinous material present adherent to the pleural surface. This led to the preliminary diagnosis of pleuropneumonia.
  • Pleural fluid samples were taken for further testing which confirmed the infection to be caused by the Streptococcus equi subspecies zooepidemicus bacterium.

Treatment and Complications

  • Various drugs and fluids were administered to the horse to manage the infection, including ceftiofur sodium, gentamicin, flunixin meglumine, butorphanol tartrate, omeprazole, and intravenous fluid boluses (Plasmalyte 148 solution).
  • There were some complications during the treatment, particularly with the drainage. Initial attempts to drain the pleural fluid through bilateral indwelling thoracic catheters were thwarted because of fibrin accumulation in the catheters. Thus, impairing their function.

It is well worth noting that this introduction does not disclose the outcome of the treatment or any conclusions made from the research yet. Further reading of the research paper would provide that information.

Cite This Article

APA
Hilton H, Pusterla N. (2009). Intrapleural fibrinolytic therapy in the management of septic pleuropneumonia in a horse. Vet Rec, 164(18), 558-559. https://doi.org/10.1136/vr.164.18.558

Publication

ISSN: 0042-4900
NlmUniqueID: 0031164
Country: England
Language: English
Volume: 164
Issue: 18
Pages: 558-559

Researcher Affiliations

Hilton, H
  • William R. Pritchard Veterinary Medical Teaching Hospital, University of California, Davis, CA 95161, USA. hghilton@ucdavis.edu
Pusterla, N

    MeSH Terms

    • Animals
    • Anti-Bacterial Agents / administration & dosage
    • Drainage
    • Euthanasia, Animal
    • Fatal Outcome
    • Fibrinolytic Agents / administration & dosage
    • Horse Diseases / diagnostic imaging
    • Horse Diseases / drug therapy
    • Horse Diseases / microbiology
    • Horses
    • Pleural Effusion / diagnostic imaging
    • Pleural Effusion / microbiology
    • Pleural Effusion / veterinary
    • Pleuropneumonia / diagnostic imaging
    • Pleuropneumonia / drug therapy
    • Pleuropneumonia / veterinary
    • Streptococcal Infections / drug therapy
    • Streptococcal Infections / veterinary
    • Streptococcus equi / isolation & purification
    • Thrombolytic Therapy / methods
    • Thrombolytic Therapy / veterinary
    • Tissue Plasminogen Activator / administration & dosage
    • Ultrasonography

    Citations

    This article has been cited 6 times.
    1. Hallowell KL, Hepworth-Warren KL, Dembek K. An updated description of bacterial pneumonia in adult horses and factors associated with death. J Vet Intern Med 2024 Sep-Oct;38(5):2766-2775.
      doi: 10.1111/jvim.17141pubmed: 39005215google scholar: lookup
    2. Taylor S. A review of equine sepsis. Equine Vet Educ 2015 Feb;27(2):99-109.
      doi: 10.1111/eve.12290pubmed: 32313390google scholar: lookup
    3. Tomlinson JE, Reef VB, Boston RC, Johnson AL. The Association of Fibrinous Pleural Effusion with Survival and Complications in Horses with Pleuropneumonia (2002-2012): 74 Cases. J Vet Intern Med 2015 Sep-Oct;29(5):1410-7.
      doi: 10.1111/jvim.13591pubmed: 26259510google scholar: lookup
    4. Tomlinson JE, Byrne E, Pusterla N, Magdesian KG, Hilton HG, McGorum B, Davis E, Schoster A, Arroyo L, Dunkel B, Carslake H, Boston RC, Johnson AL. The Use of Recombinant Tissue Plasminogen Activator (rTPA) in The Treatment of Fibrinous Pleuropneumonia in Horses: 25 Cases (2007-2012). J Vet Intern Med 2015 Sep-Oct;29(5):1403-9.
      doi: 10.1111/jvim.13594pubmed: 26256909google scholar: lookup
    5. Bäumer W, Herrling GM, Feige K. Pharmacokinetics and thrombolytic effects of the recombinant tissue-type plasminogen activator in horses. BMC Vet Res 2013 Aug 9;9:158.
      doi: 10.1186/1746-6148-9-158pubmed: 23938183google scholar: lookup
    6. Dias DP, de Lacerda Neto JC. Jugular thrombophlebitis in horses: a review of fibrinolysis, thrombus formation, and clinical management. Can Vet J 2013 Jan;54(1):65-71.
      pubmed: 23814304